These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6893074)

  • 1. Potassium iodide and propranolol in Graves' disease.
    Emerson CH; El-Zaheri MM
    N Engl J Med; 1980 Aug; 303(9):527-8. PubMed ID: 6893074
    [No Abstract]   [Full Text] [Related]  

  • 2. Potassium iodide and propranolol in Graves' disease.
    Feely J
    N Engl J Med; 1980 Aug; 303(9):528. PubMed ID: 6893075
    [No Abstract]   [Full Text] [Related]  

  • 3. The clinical and metabolic responses to early surgical treatment for hyperthyroid Graves' disease: a comparison of three pre-operative treatment regimens.
    Peden NR; Browning MC; Feely J; Forrest AL; Gunn A; Hamilton WF; Isles TE
    Q J Med; 1985 Sep; 56(221):579-91. PubMed ID: 3840600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid failure after potassium iodide treatment of diffuse toxic goiter.
    Wood LC; Maloof F
    Trans Assoc Am Physicians; 1975; 88():235-47. PubMed ID: 1243786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of potassium iodide and propranolol in preparation of patients with Graves' disease for thyroid surgery.
    Feek CM; Sawers JS; Irvine WJ; Beckett GJ; Ratcliffe WA; Toft AD
    N Engl J Med; 1980 Apr; 302(16):883-5. PubMed ID: 6892650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total thyroidectomy for the treatment of Graves' disease in children.
    Altman RP
    J Pediatr Surg; 1973 Apr; 8(2):295-300. PubMed ID: 4739708
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study of a case of recurrent multineuritis of the oculomotor nerves in a patient with secondary hypothyroidism].
    Contegiacomo P; Uncini A; Servidei S
    Acta Neurol (Napoli); 1981 Feb; 3(1):179-82. PubMed ID: 6894663
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of potassium iodide on thyroidectomy for Graves' disease: Implications for safety and operative difficulty.
    Randle RW; Bates MF; Long KL; Pitt SC; Schneider DF; Sippel RS
    Surgery; 2018 Jan; 163(1):68-72. PubMed ID: 29108701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hyperthyroidism with potassium iodide.
    Philippou G; Piperingos G; Souvatzoglou A; Koutras DA; Moulopoulos SD
    Exp Clin Endocrinol; 1991 May; 97(2-3):308-11. PubMed ID: 1915648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triiodothyronine, thyroxine, and iodine in purified thyroglobulin from patients with Graves' disease.
    Izumi M; Larsen PR
    J Clin Invest; 1977 Jun; 59(6):1105-12. PubMed ID: 577211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of gradient of thyrotropin receptor antibody and T cell subset distribution between thyroid and peripheral venous blood in patients with Graves' disease prepared for surgery with carbimazole and potassium iodide.
    Wilson R; McKillop JH; Pearson C; Burnett AK; Gunn I; McNicol AM; Thomson JA
    Clin Exp Immunol; 1988 Aug; 73(2):265-8. PubMed ID: 3263232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial: The use of potassium iodide in Graves' disease.
    Elaraj DM; Fahey TJ
    Surgery; 2018 Jan; 163(1):73-74. PubMed ID: 29108702
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical significance of propranolol therapy in patients with Graves' disease].
    Gao Y; Li H; Lin JH
    Zhonghua Nei Ke Za Zhi; 1988 Apr; 27(4):234-6, 261-2. PubMed ID: 3219941
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimizing remission rates using antithyroid drugs for Graves' disease.
    Hegedüs L
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):729-30. PubMed ID: 20050856
    [No Abstract]   [Full Text] [Related]  

  • 15. Failure to reach euthyroidism with potassium iodide and propranolol in preparation of patient with Graves' disease for surgery.
    Unger J; Couturier E; Durez M; Dor P
    J Endocrinol Invest; 1981; 4(3):367-8. PubMed ID: 6895641
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of diffuse toxic goiter].
    Balabolkin MI
    Probl Endokrinol (Mosk); 1986; 32(3):45-8. PubMed ID: 3755532
    [No Abstract]   [Full Text] [Related]  

  • 17. Control of severe thyrotoxicosis with potassium iodide and propranolol.
    Nicol EF; Irvine WJ
    Scott Med J; 1982 Apr; 27(2):172-4. PubMed ID: 7089529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
    Takata K; Amino N; Kubota S; Sasaki I; Nishihara E; Kudo T; Ito M; Fukata S; Miyauchi A
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid control of thyrotoxicosis with combined 131I, anthithyroid drugs and KI therapy.
    Refetoff S; Demeester-Mirkine N; Ermans AM; DeGroot LJ
    J Nucl Med Allied Sci; 1977; 21(1-2):23-9. PubMed ID: 578811
    [No Abstract]   [Full Text] [Related]  

  • 20. Beta-adrenergic-antagonist therapy for hyperthyroid Graves' disease.
    Utiger RD
    N Engl J Med; 1984 Jun; 310(24):1597-8. PubMed ID: 6145094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.